| Literature DB >> 34396612 |
Muhammad Ajmal Shah1, Azhar Rasul2, Rimsha Yousaf1, Muhammad Haris1, Hafiza Ishmal Faheem1, Ayesha Hamid1, Haroon Khan3, Abdul Haleem Khan4, Michael Aschner5, Gaber El-Saber Batiha6.
Abstract
The flare-up in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in December 2019 in Wuhan, China, and spread expeditiously worldwide has become a health challenge globally. The rapid transmission, absence of anti-SARS-CoV-2 drugs, and inexistence of vaccine are further exacerbating the situation. Several drugs, including chloroquine, remdesivir, and favipiravir, are presently undergoing clinical investigation to further scrutinize their effectiveness and validity in the management of COVID-19. Natural products (NPs) in general, and plants constituents specifically, are unique sources for various effective and novel drugs. Immunostimulants, including vitamins, iron, zinc, chrysin, caffeic acid, and gallic acid, act as potent weapons against COVID-19 by reinvigorating the defensive mechanisms of the immune system. Immunity boosters prevent COVID-19 by stimulating the proliferation of T-cells, B-cells, and neutrophils, neutralizing the free radicals, inhibiting the immunosuppressive agents, and promoting cytokine production. Presently, antiviral therapy includes several lead compounds, such as baicalin, glycyrrhizin, theaflavin, and herbacetin, all of which seem to act against SARS-CoV-2 via particular targets, such as blocking virus entry, attachment to host cell receptor, inhibiting viral replication, and assembly and release.Entities:
Keywords: COVID-19; SARS-CoV-2; antivirals; immunostimulants; phytochemicals
Mesh:
Substances:
Year: 2021 PMID: 34396612 PMCID: PMC8441799 DOI: 10.1002/ptr.7228
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 6.388
FIGURE 2A diagrammatic illustration of natural immunostimulators along with their sources. Immunostimulators enriched diet can help to combat the severity of COVID‐19
Nutraceutical immunity revitalizers, their sources, and their polypharmacological mechanisms
| Copper |
| Enhances the level of IL‐12p40. Promotes phagocytosis and killing by activating the immune cells. | (Richter et al., |
| Iron |
| Causes the production of toxic radicals by macrophages. Stimulates the activation of lymphocytes, NK cells, and monocytes. | (Theurl et al., |
| Magnesium |
| Protection against oxidative damage.Role in antibody synthesis.Adhesion of immune cells.Leukocyte activation. | (Gombart et al., |
| Selenium |
| Maintains antibody levels.Protection against oxidative stress via GPx.Promotes T‐cell proliferation.Production of IFN‐γ. | (Gombart et al., |
| Vitamin‐A |
| Promotes the respiratory burst of macrophages.Improves the number and function of NK cells.Improves antibody concentration | (Alpert, |
| Vitamin‐C |
| Chemotactic factor for neutrophils.Promotes antibody production.Potent antioxidant.T‐cell escalation. | (Vitamin C and the immune system | SpringerLink, |
| Vitamin‐D |
| Activates macrophages and dendritic cells.Regulates antimicrobial protein expression.Enhances respiratory burst of macrophages. | (Farhan Aslam et al., |
| Vitamin‐E |
| Promotes T‐cell multiplication.Boosts antibody response.Inhibits PGE2. | (Ibrahim & El‐Sayed, |
| Vitamin‐B6 |
| Intensifies NK cell activity.Promotes the formation of cytokines.Sustains TH1 response.Causes antibody production. | (Farhan Aslam et al., |
| Vitamin‐B9 |
| Acts as antioxidant.Regulates neutrophil function.Causes T‐cell growth. | (Ibrahim & El‐Sayed, |
| Vitamin‐B12 |
| Facilitates methylation reaction.Expedites T‐cell proliferation.Increases NK cell activity.Promotes antibody production | (Morris et al., |
| Zinc |
| Reduces ROS and RNS.Promotes the production of IL‐1, IL‐6, IL‐12, and TNF‐α.Increases NK cells.Hampers the apoptosis of B‐cells. | (Gombart et al., |
Note: IL‐12: Interleukin‐12, NK cells: natural killer cells, TNF: tumor necrosis factor, CTL: cytotoxic T‐lymphocytes, ROS: reactive oxygen species, DTH: delayed‐type hypersensitivity, INF: interferon, MCP: monocyte chemoattractant protein, TH: T‐helper cell, PGE2: prostaglandin.
FIGURE 1A diagrammatic presentation and brief strategic plan of therapeutic targets in combating COVID‐19
FIGURE 3A general schematic representation of the mechanistic pathways of natural immunity strengtheners. Different agents target different cells of the immune system. The microbe activates macrophages, which in turn alert the dendritic cells leading to the activation of T‐cells. Here, selenium, copper, and caffeic acid act on T‐cells to potentiate their killing action by promoting the activation of cytotoxic and helper T‐cells. B‐cells are also activated, and different natural agents including zinc and resveratrol promote this activation and enhance the release of antibodies. Phytochemicals such as gallic acid, iron, and plumieride stimulate macrophages, which in turn play a role in stimulating innate immunity by enhancing phagocytosis along with the different agents like beta‐D‐glucan, which promotes the release of INF
Phytochemicals as immunity revitalizers, their sources, and their polypharmacological mechanisms
| Constituents | Biological source | Mechanism of action | References |
|---|---|---|---|
| Andrographolide |
|
Promotes human peripheral blood lymphocytes. Stimulates the production of IL‐2. | (Ajaya Kumar et al., |
| β‐Glucan |
|
Activates macrophages, monocytes, neutrophils, NK cells, and dendritic cells. Stimulates the synthesis of cytokines (IL‐1α/ββ, TNF‐α, IL‐2, IFN‐γ, and IL‐12) and promotes phagocytosis. | (Mohamed et al., |
| Bromelain |
|
Triggers NK cell activity. Intensifies TNF‐α, IFN‐γ, IL‐1, IL‐2, and IL‐6 production. | (Amini et al., |
| Caffeic acid |
| Increases the level of B‐ and T‐ lymphocytes, and promotes the activity of NK cells and CTL cells. Promotes phagocytosis. | (Kilani‐Jaziri et al., |
| Chrysin |
| Promotes phagocytosis without having any adverse effect on macrophages. | (Boothapandi & Ramanibai, |
| Cytochalasin D |
|
Enhances the level of IL‐12p40. Promotes phagocytosis and killing by activating the immune cells. | (Richter et al., |
| Daidzein |
|
Stimulates the proliferation of monocytes and lymphocytes. Potentiates the phagocytosis. Reduces the DTH response. | (Maji et al., |
| Epigallocatechin gallate |
|
Stimulates the level of cytotoxic CD8 T‐lymphocytes. Promotes the release of IL‐12 Promotes Th‐1 response. | (Mohamed et al., |
| Gallic acid |
| Enhances the synthesis of IL‐12p70. TNF, INF‐γ, MCP‐1, and IL‐16. Promotes macrophage ability of phagocytosis. | (Reyes et al., |
| Kaempferol |
| It invigorates the granulocyte macrophage colony‐stimulating factor. | (Bandyopadhyay et al., |
| Plumieride |
|
Stimulates T‐ and B‐lymphocytes functioning. Promotes the functioning of macrophages. Raises the level phagocytes. Enhances the level of TNF‐γ, IL‐2, and TNF‐α in CD4 T‐lymphocytes. | (Singh et al., |
| Puerarin |
|
Enhances the proliferation of monocytes and lymphocytes. Promotes phagocytosis. Reduces DTH response. | (Maji et al., |
| Resveratrol |
|
Promotes CD4/CD8 ratio Stimulates T‐cell growth and division. Enhances B‐cell–mediated immune response. Restorative effect on NK cells. | (Mohamed et al., |
| (Z)‐Propenyl‐sec‐butyl‐disulphide |
|
Promotes the calcium influx in neutrophils. Promotes ROS production. Stimulates synthesis of phagocytes. | (Özek et al., |
Note: IL‐12: Interleukin‐12, NK cells: natural killer cells, TNF: tumor necrosis factor, CTL: cytotoxic T‐lymphocytes, ROS: reactive oxygen species, DTH: delayed‐type hypersensitivity, INF: interferon.
FIGURE 4Nature as a source of splendid antivirals holding anti‐SARS‐CoV‐2 interest with their viral life cycle restricting activity
Natural compounds, their origins, and sites of action showing the antiviral natural compounds, their origin and mechanism of action
| Constituents | Class of constituents | Biological source/origin | Mechanism of action | References |
|---|---|---|---|---|
| Apigenin | Flavone |
| Blocks the proteolytic activity of SARS‐CoV‐2 3CLpro. | (Baumann, |
| Baicalin | Flavonoid |
| Prevents viral attachment to the host cell. | (Li‐Weber, |
| β‐Sitosterol | Phytosterol |
| Blocks the SARS‐3CLpro enzyme cleavage activity. | (Lin et al., |
| Dihydrotanshinone | Biterpenoids |
| Inhibits virus entry into the cell. | (Kim et al., |
| Emodin | Anthraquinone |
| Inhibits attachment of surface spike protein of SARS‐CoV‐2 with the host cell. | (Alves et al., |
| Epigallocatechin gallate | Flavan |
| Anti‐SARS 3CLpro enzyme activity. | (Jo et al., |
| Gallocatechin gallate | Flavan |
| Anti‐SARS 3CLpro enzyme activity. | (Jo et al., |
| Gnidicin | Diterpene esters |
| Inhibit SARS‐CoV‐2 RdRp. | (Bhandurge et al., |
| Gniditrin | Diterpene esters |
| Inhibit SARS‐CoV‐2 RdRp. | (Bhandurge et al., |
| Glycyrrhizin | Saponin |
| Active against viral adsorption and penetration. | (Cinatl et al., |
| Herbacetin | Flavonol |
| Anti‐proteolytic activity of SARS‐CoV 3CLpro. | (Harborne, |
| Hesperidin | Flavonoid |
| Inhibits helicase of SARS‐CoV‐2. | (Man et al., |
|
Hesperetin | Flavonoid |
| Blocks cell‐based division of SARS‐M pro (3CLpro). | (De Clercq, |
| Indigo | Glycoside |
| Blocks the SARS‐3CLpro enzyme cleavage activity. | (Lin et al., |
| Isobavachalcone | Flavonoid |
| Inhibits the enzymatic functioning of MERS‐CoV 3CLpro. | (Jo et al., |
| Kaempferol | Flavonol |
| Blocks the 3a channel of coronavirus. | (Zakaryan et al., |
| Luteolin | Flavone |
| Inhibits attachment of spike proteins of SARS‐CoV‐2 with the host cell in an avid manner. | (Yi et al., |
|
Maco‐flavanone E | Flavonoid |
| Blocks viral assembly and release. | (Gupta et al., |
| Pectolinarin | Flavone |
| Anti‐SARS 3CLpro enzyme activity. | (Cho et al., |
| Puerarin | Iso‐flavone |
| Anti‐SARS CoV 3CLpro proteolytic activity. | (Jo et al., |
| Phaithanthrin | Alkaloid |
| Inhibition of PLpro activity. | (Wu, Liu, et al., |
| Phyllaemblicin | Terpenoids |
| Inhibits helicase activity of SARS‐CoV‐2. | (Wu, Liu, et al., |
| Phyllaemblinol | Terpenoids |
| Anti‐SARS‐CoV‐2 helicase activity. | (Wu, Liu, et al., |
| Platycodin D | Triterpenoidal saponin |
| Inhibit PLpro activity of SARS‐CoV‐2. | (Khan et al., |
| Quercetin | Flavonol |
| Inhibition of SARS‐CoV‐2 3CLpro. | (Wu et al., |
| Rhoifolin | Flavone |
| Inhibits the enzymatic action of SARS‐CoV‐2 3CLpro. | (Jo et al., |
| Rutin | Glycoside |
| Inhibits the helicase of SARS‐CoV‐2. | (Ganeshpurkar & Saluja, |
| Saikosaponin | Terpenoids |
| Impedes early stage of HCOV‐22E9 infection including the attachment and penetration of virus. | (Cheng et al., |
| Sinigrin | Glucoside |
| Blocks the SARS‐3CLpro enzyme cleavage activity. | (Lin et al., |
| Sugetriol‐3,9‐diacetate | Sesqui‐terpenoids |
| Anti‐SARS‐CoV‐2 PLpro activity. | (Kim et al., |
| Tetrandrine | Alkaloid |
| Blockage of spike and nucleocapsid protein expression in HCOV‐OC43. | (Kim et al., |
| Tetra‐O‐galloyl‐β‐D‐glucose | Gallate Ester |
| Attaches with the surface spike protein of SARS‐CoV‐2 in an avid manner. | (Yi et al., |
| Theaflavin | Flavonoid |
| Inhibition of SARS‐CoV‐2 RdRp. | (Leung et al., |
| Vibsanol A | Lignan |
| Blocks viral assembly and release. | (Gupta et al., |
Note: SARS‐CoV: Severe acute respiratory syndrome coronavirus, 3CLpro: 3 chymotrypsin‐like protease, M pro: main protease, RdRp: RNA‐dependent RNA polymerase, MERS‐CoV: Middle East respiratory syndrome coronavirus, PLpro: papain‐like protease.
FIGURE 5Diagrammatic representation of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) viral life cycle and potential drug targets. Proposed targets of selected repurposed and investigational products are noted as shown in the figure. These host‐based pathways are targetable to control viral infection
Factors involved in HCoV, virion assembly, and release
| Host factor(s) | HCoV (other CoV) | Function | References |
|---|---|---|---|
| Tubulin | HCoV‐229E, HCoV‐NL63, (TGEV) | Binds to the cytosolic domain of S protein; facilitates the assembly and release of the virus. | (Rüdiger et al., |
| Β‐Actin | (IBV) | Binds to M protein; promotes particle assembly and release. | (Wang et al., |
| Vimentin | (TGEV) | Binds to N protein; ease the process of viral assembly and release. | (Zhang et al., |
Note: HCoV‐229E, human coronavirus‐229E; HCoV‐NL63, human coronavirus‐NL63; TGEV, transmissible gastroenteritis virus; IBV, infectious bronchitis virus.